- 1. 3 Self-Sustaining Sequence Replication
- [Molecular, 3 Self-Sustaining Sequence Replication ( HL7V3.0 )] (UMLS (HL7) C1553155) =Laboratory Procedure =ObservationMethod;
| - 51. SEC MALIG NEO RESP NEC
- [ ] (UMLS (ICD9CM) C0348383) =Neoplastic Process
|
- 2. S element
- [use this term only for elemental sulfur; for other compounds see SULFUR COMPOUND. ( CSP )] (UMLS (CSP) C0038774) =Pharmacologic Substance; Element, Ion, or Isotope =Element;
sulfur compound;
Chalcogens;
[DE752] ANTIACNE AGENTS, TOPICAL;
[DE500] KERATOLYTICS/CAUSTICS, TOPICAL;
=Colloid sulfur;
SULFUR,SUBLIMED;
SULFUR,COLLOIDAL;
SULFUR OINT,TOP;
Sulfur 0.1 MG/MG;
SULFUR 0.44 %;
SULFUR 6.4 %;
SULFUR 8 %;
SULFUR 10 %;
SULFUR 3 %;
SULFUR 4 %;
SULFUR 5 %;
SULFUR 2 % | - 52. SEC MALIG NEO URIN NEC
- [ ] (UMLS (ICD9CM) C0153686) =Neoplastic Process
|
- 3. Se
- [element with the atomic symbol Se, atomic number 34; an essential micronutrient for mammals and other animals but toxic in large amounts; protects intracellular structures against oxidative damage. ( CSP )] (UMLS (NCI) C0036581) =Biologically Active Substance; Hazardous or Poisonous Substance; Element, Ion, or Isotope =Element;
Mineral;
Micronutrient;
Chalcogens;
[TN499] ELECTROLYTES/MINERALS, OTHER;
=Selenious Acid;
selenium disulfide;
Selenate, Sodium;
CENTRUM TAB;
CERTAGEN TAB;
CHOICE DM LIQUID,BOTTLE,1000ML;
ISOCAL LIQUID,CAN,240ML;
ISOCAL LIQUID,CAN,360ML;
ISOCAL LIQUID,CAN,960ML;
Selenium 0.1 MG;
Selenium 0.05 MG;
Selenium 0.2 MG;
SELENIUM 0.01 MG;
SELENIUM 0.053 MCG/ML;
SELENIUM 10 MCG;
SELENIUM 12 MCG/240ML;
SELENIUM 13 MCG/240ML;
SELENIUM 14 MCG/240ML;
SELENIUM 15 MCG;
SELENIUM 16.6 MCG/240ML;
SELENIUM 17 MCG/240ML;
SELENIUM 18 MCG/240ML;
SELENIUM 20 MCG/ML;
SELENIUM 24 MCG/240ML;
SELENIUM 25 MCG;
SELENIUM 40 MCG;
SELENIUM 5.4 MCG/240ML;
SELENIUM 60 MCG/ML;
SELENIUM 70 MCG;
SELENIUM 9 MCG/240ML | - 53. SEC UTERINE INERT-ANTEPA
- [ ] (UMLS (ICD9CM) C0157244) =Disease or Syndrome
|
- 4. SE
- [A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway. (NCI) ( NCI )] (UMLS (NCI) C0038995) =Geographic Area
| - 54. SEC UTERINE INERT-DELIV
- [ ] (UMLS (ICD9CM) C0157243) =Disease or Syndrome
|
- 5. Sea
- (UMLS (HL7) C1552508) =Health Care Related Organization ;
=Ambulance;
| - 55. SEC UTERINE INERT-UNSPEC
- [ ] (UMLS (ICD9CM) C0157242) =Disease or Syndrome
|
- 6. SEA
- [A bacterial enterotoxin with potential immunostimulatory activity. Staphylococcal enterotoxin A (SEA), a gram positive bacterial superantigen (SAg), is a potent stimulator of T-cell activation. SEA superantigen binds directly to class II major histocompatibility complex (MHC) molecules and to the V beta region of the T-cell receptor (TCR), leading to an amplified T-cell response. In response to SEA, both CD4+ and CD8+ cells proliferate, secrete cytokines and demonstrate enhanced cytotoxic activity against a broad range of antigens. Vaccination with the SEA protein, administered by direct transfection into tumor cells, may elicit a non-specific cytotoxic T-cell (CTL) response and result in decreased tumor cell growth. ( NCI )] (UMLS (NCI) C0059385) =Amino Acid, Peptide, or Protein; Hazardous or Poisonous Substance ;
| - 56. SEC VITREORETINA DEGEN
- [ ] (UMLS (ICD9CM) C0154859) =Disease or Syndrome
|
- 7. sea anemone
- [The order Actiniaria, in the class ANTHOZOA, comprised of large, solitary polyps. All species are carnivorous. ( MSH )] (UMLS (CSP) C0036483) =Invertebrate ;
| - 57. SecB protein
- [ ] (UMLS (CSP) C0074244) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 8. sea hare
- [ ] (UMLS (CSP) C0597896) =Invertebrate
| - 58. Secnidazole
- (UMLS (NCI) C0074246) =Organic Chemical; Pharmacologic Substance ;
|
- 9. sea lily
- [ ] (UMLS (CSP) C0598344) =Invertebrate
| - 59. SECOBARBITAL
- [A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity. ( MSH )] (UMLS (NCI) C0036516) =Organic Chemical; Pharmacologic Substance =barbiturate;
[CN301] BARBITURIC ACID DERIVATIVE, SEDATIVES/HYPNOTICS =SECOBARBITAL SODIUM;
|
- 10. sea lion
- [A group comprised of several species of aquatic carnivores in different genera, in the family Otariidae. In comparison to FUR SEALS, they have shorter, less dense hair. ( MSH )] (UMLS (CSP) C0036486) =Mammal ;
| - 60. second
- (UMLS (HL7) C1561503) =Idea or Concept =Precision;
|
- 11. sea otter
- [ ] (UMLS (CSP) C1005345) =Mammal
| - 61. Second
- [Coming next after the first in position in space or time or degree or magnitude. ( NCI )] (UMLS (NCI) C0205436) =Quantitative Concept
|
- 12. Sea Sickness
- (UMLS (NCI) C0036494) =Disease or Syndrome ;
| - 62. second (continuous)
- (UMLS (HL7) C1550735) =Temporal Concept =CalendarCycleTwoLetter;
|
- 13. sea slug
- [ ] (UMLS (CSP) C0599688) =Invertebrate ;
| - 63. Second ancillary
- (UMLS (HL7) C1549482) =Idea or Concept =Policy type;
|
- 14. sea snail
- [ ] (UMLS (CSP) C0599795) =Invertebrate ;
| - 64. second assistant surgeon
- [In a typical surgery setting the assistant who primarily holds the hooks. ( HL7V3.0 )] (UMLS (HL7) C1550492) =Professional or Occupational Group =ParticipationFunction;
|
- 15. sea squirt
- [subphylum of chordates intermediate between the invertebrates and the true vertebrates; includes the Ascidians. ( CSP )] (UMLS (CSP) C0042056) =Invertebrate ;
=Chordata;
| - 65. second cancer
- [Refers to a new primary cancer that is caused by previous cancer treatment, or a new primary cancer in a person with a history of cancer. ( NCI )] (UMLS (NCI) C0751623) secondary cancer;
Secondary Malignancy;
Secondary Malignancy (After Treatment of Primary Cancer);
Secondary Malignant Neoplasm;
=Neoplastic Process ;
|
- 16. sea water
- [The SALINE water of OCEANS AND SEAS that provides habitat for marine organisms. ( MSH )] (UMLS (CSP) C0036499) =Substance ;
| - 66. SECOND CARDIOMYOPATH NOS
- (UMLS (ICD9CM) C0036529) =Disease or Syndrome ;
|
- 17. Sea-Blue Histiocyte
- (UMLS (NCI) C0333836) =Cell
| - 67. Second Degree Uterine Prolapse
- (UMLS (NCI) C0269126) =Acquired Abnormality
|
- 18. seafood
- [fish and shellfish used as food or suitable for food. ( CSP )] (UMLS (CSP) C0206208) =Food ;
=meat;
| - 68. Second intensive care unit
- (UMLS (HL7) C1549472) =Idea or Concept =Room type;
|
- 19. seafood poisoning
- [ ] (UMLS (CSP) C0597426) =Disease or Syndrome =food poisoning;
| - 69. SECOND IRITIS, NONINFEC
- [ ] (UMLS (ICD9CM) C0154912) =Disease or Syndrome
|
- 20. seal
- [ ] (UMLS (CSP) C0036492) =Mammal ;
| - 70. Second major medical
- (UMLS (HL7) C1549483) =Idea or Concept =Policy type;
|
- 21. Sealant
- [A resinous material designed to be applied to the occlusal surfaces of posterior teeth to prevent occlusal decay by filling in the fissures and/or crevices of the tooth. ( NCI )] (UMLS (NCI) C0729415) =Biomedical or Dental Material ;
| - 71. SECOND MALIG NEO ADRENAL
- [ ] (UMLS (ICD9CM) C0153691) =Neoplastic Process
|
- 22. sealpox virus
- [ ] (UMLS (CSP) C0319266) =Virus
| - 72. SECOND MALIG NEO GENITAL
- [ ] (UMLS (ICD9CM) C0153693) =Neoplastic Process
|
- 23. Sealyham Terrier
- [The Sealyham Terriers have a large nose and powerful jaws with very long canines. Its front legs are short and straight; the hind legs are powerful and muscular. The coat is bristly, coarse, and long and comes in white or yellowish-white. Height: Not more then 12 inches (30 cm.) Weight: Maximum 20 pounds (9 kg.) ( NCI )] (UMLS (NCI) C0324443) =Mammal
| - 73. second messenger
- [diverse family of low molecular weight compounds such as cyclic AMP and calcium ions which transmit the biological signals initiated by receptor-ligand binding at the cell surface to intracellular targets such as gene expression. ( CSP )] (UMLS (CSP) C1508748) =Biologically Active Substance ;
=Signal Transduction;
|
- 24. search
- [A name intended for use in searching or matching. ( HL7V3.0 )] (UMLS (HL7) C1552603) =Idea or Concept =EntityNameUse;
=phonetic;
Soundex | - 74. Second nearest lab
- (UMLS (HL7) C1548584) =Intellectual Product =Location Relationship ID;
|
- 25. season
- [one of the four quarters into which the year is commonly divided. ( CSP )] (UMLS (CSP) C0036497) =Temporal Concept ;
=climate;
| - 75. Second nearest pharmacy
- (UMLS (HL7) C1548587) =Intellectual Product =Location Relationship ID;
|
- 26. seasonal affective disorder
- [specific disorder usually appearing in the second or third decade, characterized by symptoms of depression between late fall and early spring, sometimes followed by mania or hypomania; intense light is reportedly therapeutic. ( CSP )] (UMLS (CSP) C0085159) =Mental or Behavioral Dysfunction ;
=Alteraciones depresivas;
Mood Disorders | - 76. second of the minute
- (UMLS (HL7) C1549037) =Temporal Concept =Calendar alignment;
CalendarCycleTwoLetter;
CalendarCycleOneLetter;
|
- 27. Seasonale
- (UMLS (NCI) C1330524) =Steroid; Pharmacologic Substance; Hormone
| - 77. Second Opinion
- (UMLS (HL7) C1548433) =Idea or Concept =Referral disposition;
|
- 28. Seat Belt Exemption
- (UMLS (HL7) C1548914) =Health Care Activity =Consent Type;
| - 78. Second Opinion
- (UMLS (HL7) C1548632) =Idea or Concept =Referral reason;
|
- 29. Seated
- [The state or act of one who sits; the posture of one who occupies a seat. ( NCI )] (UMLS (NCI) C0728713) Sit;
Sitting =Finding ;
| - 79. Second Opinion Documentation Received
- (UMLS (HL7) C1550426) =Finding =HL7 Vocabulary Version 2.5;
|
- 30. SEB
- [A bacterial enterotoxin with potential immunostimulatory activity. Staphylococcal enterotoxin B (SEB), a gram positive superantigen produced by Staphylococus aureus, is a potent stimulator of T-cell activation. SEB binds directly to class II major histocompatibility complex (MHC) molecules and the V beta region of the T-cell receptor (TCR), leading to an amplified T-cell response. In response to SEB, both CD4+ and CD8+ cells proliferate, secrete cytokines and demonstrate enhanced cytotoxic activity against a broad range of antigens. Co-administration of SEB with interleukin-2 (IL-2) by direct injection into tumor cells, may induce clonal T-cell expansion and potentiate apoptosis of tumor cells, resulting in decreased tumor growth. ( NCI )] (UMLS (NCI) C0059386) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 80. Second Opinion Status
- (UMLS (HL7) C1550425) =Finding =HL7 Vocabulary Version 2.5;
|
- 31. Sebaceous cyst
- [Intradermal or subcutaneous saclike structure, the wall of which is stratified epithelium containing keratohyalin granules.(MSH)] (UMLS (ICPC) C0014511) (Sebaceous cyst; KISTE BILGORTSUA; Aterom; Atheroom kyste/epitheel kyste; ATEROOMA/TALIRAUHASEN TUKKEUMA; Kyste sebace; Talgdruesenzyste/Atherom; tzista sibaseus-SEBACEOUS CYST; cysta sebacea; Cisti sebacea; ATHEROM; Quisto sebaceo; Quiste sebaceo; ATEROM) =Anatomical Abnormality ;
=cyst; Diagnosis/Diseases Component; Integument; | - 81. Second Pharyngeal Pouch
- (UMLS (NCI) C0231069) =Embryonic Structure
|
- 32. sebaceous gland
- [small, sacculated organs found within the dermis which secrete sebum; ducts from most sebaceous glands open into a hair follicle but some open on the general surface of the skin. ( CSP )] (UMLS (CSP) C0036505) =Body Part, Organ, or Organ Component ;
=exocrine gland;
Integument | - 82. Second private room
- (UMLS (HL7) C1549473) =Idea or Concept =Room type;
|
- 33. Sebaceous Gland Duct
- (UMLS (NCI) C1182773) =Body Part, Organ, or Organ Component
| - 83. Second semi-private room
- (UMLS (HL7) C1549474) =Idea or Concept =Room type;
|
- 34. sebaceous gland neoplasm
- [new abnormal sebaceous gland tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C0036503) =Neoplastic Process ;
=Diseases of sebaceous glands;
Neoplasm of Skin | - 84. SECOND SYPH VISCERA NEC
- [ ] (UMLS (ICD9CM) C0153150) =Disease or Syndrome
|
- 35. Sebaceous Hyperplasia
- (UMLS (NCI) C0406484) =Disease or Syndrome
| - 85. SECOND SYPHILIS RELAPSE
- [ ] (UMLS (ICD9CM) C0153151) =Disease or Syndrome
|
- 36. SEBORRHEA CAPITIS
- (UMLS (ICD9CM) C0221244) =Disease or Syndrome ;
| - 86. SECOND THROMBOCYTOPENIA
- [ ] (UMLS (ICD9CM) C0154301) =Disease or Syndrome
|
- 37. Seborrheic dermatitis
- [A chronic inflammatory disease of the skin with unknown etiology. It is characterized by moderate ERYTHEMA, dry, moist, or greasy (SEBACEOUS GLAND) scaling and yellow crusted patches on various areas, especially the scalp, that exfoliate as dandruff. Seborrheic dermatitis is common in children and adolescents with HIV INFECTIONS.(MSH)] (UMLS (ICPC) C0036508) (Seborrheic dermatitis; BILGORRERI DERMATITIA/ BESTE ZENBAIT DERMATOSI ERITEMATOSO; Seboroisk eksem/an erytem dermat; Seborroisch eczeem/roos; SEBORROINEN EKSEEMA/IHOTTUMA; Dermatite seborrheique; Seborrhoische Dermatitis/Schuppen; dermatitis seboreit o kol dermatitis eritematotit-SEBORRHOIC; seborrheas dermatitis; Dermatite seborroica; SEBOROISK EKSEM/DERMATOSE/FLASS; Dermatite seborreica; Dermatitis seborreica; SEBORROISK DERMATIT) =Disease or Syndrome ;
=dermatitis; Diseases of sebaceous glands; Skin Diseases, Eczematous; Skin Diseases, Papulosquamous; Diagnosis/Diseases Component; Integument | - 87. second transplant
- [ ] (UMLS (CSP) C0599346) =Therapeutic or Preventive Procedure ;
|
- 38. Seborrheic Keratosis of the Vulva
- (UMLS (NCI) C1336981) Seborrheic Keratosis of Vulva;
Vulvar Seborrheic Keratosis =Neoplastic Process ;
| - 88. Secondary
- [Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value. ( NCI )] (UMLS (NCI) C0175668) =Temporal Concept ;
|
- 39. sebum
- [(SEE-bum) An oily substance produced by certain glands in the skin. ( NCI )] (UMLS (NCI) C0036511) =Body Substance ;
| - 89. Secondary Acute Granulocytic Leukemia
- [An acute myeloid leukemia secondary to a myelodysplastic syndrome or therapy-related. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C0280449) =Neoplastic Process
|
- 40. SEC
- [Staphylococcal enterotoxin C. A superantigen and member of a family of genetically related proteins produced by Staphylococcus aureus and Streptococcus pyogenes. An extremely potent activator of T lymphocytes when presented on MHC class II antigens. ( NCI )] (UMLS (NCI) C0059387) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 90. Secondary Amyloidosis
- (UMLS (NCI) C0221014) =Disease or Syndrome
|
- 41. Sec
- [An unusual amino acid of proteins, the selenium analogue of cysteine, in which a selenium atom replaces sulphur. Involved in the catalytic mechanism of seleno enzymes such as formate dehydrogenase of E. coli and mammalian glutathione peroxidase. ( NCI )] (UMLS (NCI) C0074289) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 91. Secondary and recurrent hemorrhage as an early complication of trauma
- [ ] (UMLS (ICD9CM) C0274267) =Injury or Poisoning
|
- 42. SEC FOCAL HYPERHIDROSIS
- [ ] (UMLS (ICD9CM) C1456136) Secondary focal hyperhidrosis;
=Disease or Syndrome | - 92. secondary antibody deficiency
- [ ] (UMLS (CSP) C0597744) =Disease or Syndrome ;
|
- 43. SEC HYPERCOAGULABLE ST
- [ ] (UMLS (ICD9CM) C1456282) Secondary hypercoagulable state;
=Disease or Syndrome | - 93. Secondary Carcinoma
- (UMLS (NCI) C0085668) =Neoplastic Process
|
- 44. SEC HYPERPARATHYRD-RENAL
- [ ] (UMLS (ICD9CM) C0271847) =Disease or Syndrome
| - 94. Secondary Chondrosarcoma
- [A low grade chondrosarcoma arising from a pre-existing benign chondrogenic neoplasm. It is characterized by the presence of myxoid changes and tissue invasion. When associated with Maffucci Syndrome, there is an increase in cellularity and nuclear atypia. Clinical presentation includes sudden pain or increased swelling. ( NCI )] (UMLS (NCI) C1335938) =Neoplastic Process
|
- 45. SEC HYPRPRTHYRD NONRENAL
- [ ] (UMLS (ICD9CM) C1456268) Secondary hyperparathyroidism, non-renal;
=Disease or Syndrome | - 95. SECONDARY CORNEAL EDEMA
- [ ] (UMLS (ICD9CM) C0155110) =Disease or Syndrome ;
|
- 46. SEC MAL NEO BRAIN/SPINE
- [ ] (UMLS (ICD9CM) C0153688) =Neoplastic Process
| - 96. secondary degeneration
- [fatty degeneration of a nerve fiber which has been severed from its nutritive centers. ( CSP )] (UMLS (CSP) C0043020) =Cell or Molecular Dysfunction =Nerve Degeneration;
|
- 47. SEC MAL NEO GI NEC
- [ ] (UMLS (ICD9CM) C0153683) =Neoplastic Process
| - 97. Secondary hypertension
- [ ] (UMLS (ICD9CM) C0155616) =Disease or Syndrome
|
- 48. SEC MAL NEO PERITONEUM
- (UMLS (ICD9CM) C0036528) =Neoplastic Process ;
| - 98. secondary immune deficiency
- [ ] (UMLS (CSP) C0597745) =Disease or Syndrome ;
|
- 49. SEC MALIG NEO LG BOWEL
- [ ] (UMLS (ICD9CM) C0153681) =Neoplastic Process
| - 99. secondary infection
- [infection by a microorganism following an infection by another kind of microorganism. ( CSP )] (UMLS (CSP) C0442886) =Disease or Syndrome =infection;
|
- 50. SEC MALIG NEO NERVE NEC
- [ ] (UMLS (ICD9CM) C0153689) =Neoplastic Process
| - 100. SECONDARY INSERT LENS
- [ ] (UMLS (ICD9CM) C0197750) =Therapeutic or Preventive Procedure
|
home
